This study focuses on understanding the functional causes of genomic associations with traits by utilizing systems approaches and intermediate molecular phenotypes. The researchers investigated the effects of annotated loss-of-function (LoF) mutations on 122 serum metabolites in two populations of African-Americans and European-Americans from the Atherosclerosis Risk in Communities study. They built metabolomic causal networks for each population separately and used structural equation modeling to assess their findings. The researchers validated their findings with independent samples. Using methods based on concepts of Mendelian randomization, the study showed that some affected metabolites are risk predictors in the causal pathway of disease. For example, LoF mutations in the gene KIAA1755 were found to elevate the levels of eicosapentaenoate, an essential fatty acid clinically associated with increased essential hypertension. This gene was also identified to be involved in the pathway to triglycerides, where both triglycerides and essential hypertension are risk factors for metabolomic disorder and heart attack. Additionally, the study identified that the gene CLDN17, harboring loss-of-function mutations, had pleiotropic actions on metabolites from amino acid and lipid pathways. By integrating several biological processes using systems biology approaches for analyzing metabolomics and genetic data, this study provides insights into how genetic variants may functionally connect with complex diseases. Overall, this research contributes to a better understanding of the functional causes underlying genomic associations with traits by investigating intermediate molecular phenotypes and building causal networks. These findings have implications for identifying potential risk predictors and pathways related to complex diseases such as essential hypertension and metabolomic disorders.
A study was done to understand why certain traits are connected to our genes. They looked at how changes in our genes affect the chemicals in our bodies, specifically in African-Americans and European-Americans. They made diagrams to show how these chemicals are connected. They used a special kind of math to see if their findings were true. They also checked their results with other groups of people to make sure they were right. They found that some chemicals can predict if someone will get sick, and they discovered two genes that are involved in causing high blood pressure and heart problems. This study helps us understand how our genes can cause diseases and find ways to prevent them."
Definitions
- Genomic associations: connections between specific parts of our DNA (genes) and certain traits or characteristics
- Loss-of-function mutations: changes or mistakes in our DNA that stop a gene from working properly
- Serum metabolites: chemicals found in our blood that help our body function
- Structural equation modeling: a type of math used to understand relationships between different factors or variables
- Validated findings: checked if the results were correct by doing the same experiment again with different people
- Risk predictors: things that can help us predict if someone is likely to get sick or have a health problem
- Causal pathway: the series of events or steps that lead from one thing causing another thing
- Gene KIAA1755: a specific part of our DNA that is responsible for making certain proteins
- Eicosapentaeno
Understanding the Functional Causes of Genomic Associations with Traits
Genetic variants have been linked to a variety of complex diseases, but the functional causes underlying these associations remain largely unknown. A recent study conducted by researchers at the University of Michigan aimed to better understand these functional causes by utilizing systems approaches and intermediate molecular phenotypes. The findings from this research could provide valuable insights into potential risk predictors and pathways related to complex diseases such as essential hypertension and metabolomic disorders.
Methods
The researchers investigated the effects of annotated loss-of-function (LoF) mutations on 122 serum metabolites in two populations: African-Americans and European-Americans from the Atherosclerosis Risk in Communities study. They built metabolomic causal networks for each population separately using structural equation modeling, which is a statistical technique used to assess relationships between variables. To validate their findings, they also used independent samples based on concepts of Mendelian randomization.
Findings
The results showed that some affected metabolites are risk predictors in the causal pathway of disease. For example, LoF mutations in the gene KIAA1755 were found to elevate levels of eicosapentaenoate, an essential fatty acid clinically associated with increased essential hypertension. This gene was also identified as being involved in a pathway leading to triglycerides – both triglycerides and essential hypertension are risk factors for metabolomic disorder and heart attack. Additionally, CLDN17 – harboring loss-of-function mutations – had pleiotropic actions on metabolites from amino acid and lipid pathways.
Implications
By integrating several biological processes using systems biology approaches for analyzing metabolomics and genetic data, this study provides insights into how genetic variants may functionally connect with complex diseases such as essential hypertension and metabolomic disorders. These findings have implications for identifying potential risk predictors and pathways related to these conditions, which could lead to more targeted treatments or preventive measures against them in future studies.
Overall, this research contributes significantly towards understanding the functional causes underlying genomic associations with traits by investigating intermediate molecular phenotypes and building causal networks – providing valuable information that can be used when developing strategies for treating or preventing complex diseases in humans
Background: Many genome-wide association studies have detected genomic regions associated with traits, yet understanding the functional causes of association often remains elusive. Utilizing systems approaches and focusing on intermediate molecular phenotypes might facilitate biologic understanding. Results: The availability of exome sequencing of two populations of African-Americans and European-Americans from the Atherosclerosis Risk in Communities study allowed us to investigate the effects of annotated loss-of-function (LoF) mutations on 122 serum metabolites. To assess the findings, we built metabolomic causal networks for each population separately and utilized structural equation modeling. We then validated our findings with a set of independent samples. By use of methods based on concepts of Mendelian randomization of genetic variants, we showed that some of the affected metabolites are risk predictors in the causal pathway of disease. For example, LoF mutations in the gene KIAA1755 were identified to elevate the levels of eicosapentaenoate (p-value=5E-14), an essential fatty acid clinically identified to increase essential hypertension. We showed that this gene is in the pathway to triglycerides, where both triglycerides and essential hypertension are risk factors of metabolomic disorder and heart attack. We also identified that the gene CLDN17, harboring loss-of-function mutations, had pleiotropic actions on metabolites from amino acid and lipid pathways. Conclusion: Using systems biology approaches for the analysis of metabolomics and genetic data, we integrated several biological processes, which lead to findings that may functionally connect genetic variants with complex diseases.
